Metabolites of hexamethyldisiloxane and decamethylcyclopentasiloxane in Fischer 344 rat urine - A comparison of a linear and a cyclic siloxane

Drug Metabolism and Disposition

Volumn 31, Issue 2, 2003, Pages 206-214

  Varaprath, Sudarsanan ^a   McMahon, Joan M ^a   Plotzke, Kathleen P ^a  

^a DOW CORNING CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAMETHYLCYCLOPENTASILOXANE; DRUG METABOLITE; SILOXANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DERIVATIZATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; LINEAR SYSTEM; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SAMPLING; SOLID PHASE EXTRACTION; SOLUBILITY;

ANIMALS; FEMALE; MOLECULAR STRUCTURE; RATS; RATS, INBRED F344; SILOXANES; URINE;

ANIMALIA;

EID: 0037309959     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.2.206     Document Type: Article

References (17)

1. Andersen ME, Sarangapani R, Reitz RH, Gallavan RH, Dobrev ID, and Plotzke KP (2001) Physiological modeling reveals novel pharmacokinetic behavior for inhaled octamethylcyclotetrasiloxane in rats. Toxicol Sci 60:214-231.
2. Bennett DR and Aberg B (1975) 2,6-cis- Diphenylhexamethylcyclotetrasiloxane chemistry, analytical chemistry, biological effects and excretion. Acta Pharmacol Toxicol 36:1-147,
3. 5) following a 3-month nose-only exposure in Fischer 344 rats. Toxicol Sci 43:230-240.
4. Cameron GM, Haala H, and Kuo AL (1986) The use of volatile silicones in cosmetic applications. Parfuem Kosmet A67:384-386 and 388-389.
5. Cassidy LS, Dotti A, Kolesar GB, Dochterman LW, Meeks RG, and Chevalier HJ (2001) Hexamethyldisiloxane: A 13-week subchronic whole-body vapor inhalation toxicity study in Fischer 344 rats, Int J Toxicol 20:391-399.
6. Flanningam OL (1986) Vapor pressures of polydimethylsiloxanes (oligomers). J Chem Eng Data 31:266.
7. Hurd CB (1946) Siloxanes. I. The specific volume and viscosity in relation to temperature and constitution. J Am Chem Soc 68:364.
8. McKim JM, Kolesar GB, Jean PA, Meeker LS, Wilga PC, Schoonhoven R, Swenberg JA, Goodman JA, Gallavan RH, and Meeks RG (2001) Repeated inhalation exposure to octamethylcyclotetrasiloxane produces hepatomegaly, transient hepatic hyperplasis and sustained hypertrophy in female Fischer 344 rats in a manner similar to phenobarbital. Toxicol Appl Pharmacol 172:83-92.
9. 4) as an inducer of rat hepatic microsomal cytochrome P450, UDP-glucuronysltransferase, an epoxide hydrolase: a 28-day inhalation study. Toxicol Sci 41:29-41.
10. 4), Drug Metab Dispos, 28:192-204.
11. Simmler W, Niederprum H, and Sattleger H (1969) inventors, Farbenfabriken Bayer Aktiengesellschaft, assignee. 2,2,5,5-Tetramehyl-2,5-disila-1,3-dioxalane and process therefor. US Patent 3,444,228. 1969 May 13.
12. Tacke R, Lange H, Bentlage A, Sheldrick W, and Ernst L (1983) 2,2,5,5-Tetramethyl-1,4-dioxa-2,5-disilacyclohexanes. Z Naturforsch Teil B Anorg Chem Org Chem 38:190-193.
13. 14C-labeled cyclic and linear siloxanes. J Organomet Chem 572:37-47.
14. Varaprath S and Cao L (2000) Efficient solid phase extraction procedures for organo siloxanes and silanols from aqueous and biological matrices. J Liq Chromatogr Relat Technol 23:1539-1553.
15. Varaprath S, Frye CL, and Hamelink JL (1996) Aqueous solubility of permethylsiloxanes (silicones). Environ Toxicol Chem 8:1263-1265.
16. Varaprath S, Salyers KL, Plotzke KP, and Nanavati S (1998) Extraction of octamethylcyclotetrasiloxane and its metabolites from biological matrices. Anal Biochem 256:14-22.
17. 4) in rat urine. Drug Metab Dispos 27:1267-1273.